Jasbir Seehra is the founder of Keros Therapeutics. Keros Therapeutics has raised $79M in total funding. Latest round: Series C.
Jasbir S. Seehra is the President and CEO of Keros Therapeutics, a biotechnology company focused on discovering, developing, and commercializing novel treatments for hematologic and musculoskeletal disorders. The company recently closed a $56 million Series C financing, bringing its total venture funding to $78.5 million. Keros Therapeutics leverages a deep understanding of the biology relevant to the role of members of the TGF-ß family of proteins.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide